Stress Inoculation Training (SIT): An Evidence-Based, Military Aligned Psychological Performance and Health Sustainment Prototype

NCT ID: NCT06656780

Last Updated: 2025-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-31

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to demonstrate the feasibility of augmenting existing/traditional Navy military training with the manualized SIT Core Protocol (CP) utilizing the established augmentation procedure set as measured by feasibility, utility, and satisfaction metrics (CSQ-8) and to examine the relative effectiveness of the SIT-CP by comparison to standard military training in a controlled trial examining outcomes of stress tolerance, psychological health, resilience and occupational performance in Sailors undergoing DCA Firefighting Training (pre- to post-training), while collecting implementation data.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress, Psychological

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SIT + Damage Control Assessment & Firefighting (DCA-FF)

Group Type EXPERIMENTAL

SIT

Intervention Type BEHAVIORAL

Participants will undergo 2 day (8 hours each) Stress Inoculation Training . This will be done in 3 steps:

Step 1: focus on education about the human body and brain and shift to hands on skills practice to improve performance in stressful conditions and is designed to improve self-and-situational awareness and the ability to manipulate reactions and responses in the body on purpose to enhance performance

Step 2: focuses on improving mental self-awareness and gaining skills in Mental Agility and Mental Flexibility

Step 3: participants will have specific simulations and real-world opportunities to practice the skills learnt.

DCA-FF

Intervention Type BEHAVIORAL

Participants will undergo 8-week Standard Firefighting Training

DCA-FF

Group Type ACTIVE_COMPARATOR

DCA-FF

Intervention Type BEHAVIORAL

Participants will undergo 8-week Standard Firefighting Training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SIT

Participants will undergo 2 day (8 hours each) Stress Inoculation Training . This will be done in 3 steps:

Step 1: focus on education about the human body and brain and shift to hands on skills practice to improve performance in stressful conditions and is designed to improve self-and-situational awareness and the ability to manipulate reactions and responses in the body on purpose to enhance performance

Step 2: focuses on improving mental self-awareness and gaining skills in Mental Agility and Mental Flexibility

Step 3: participants will have specific simulations and real-world opportunities to practice the skills learnt.

Intervention Type BEHAVIORAL

DCA-FF

Participants will undergo 8-week Standard Firefighting Training

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* US Navy service members on Active Duty or Reserve status
* be fluent in English.
* be capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form and in this protocol.
* have access to a SmartPhone, computer, or tablet to utilize and access the virtual classroom.
* agree to undergo psychometric and operational performance testing and participate in ongoing assessments throughout the study duration.
* be willing to comply with all study procedures, able to complete all assessments independently, and available for the duration of the study (with reasonable accommodations for military operational demands as they arise).

Exclusion Criteria

* Active suicidal ideation as assessed by the Investigator at screening or as identified during the study.
* Clinically significant history of psychotic disorder, bipolar spectrum disorder, or neurodegenerative disease/dementia as assessed by the Investigator.
* Active severe substance abuse as assessed by the investigator in accordance with The Diagnostic and Statistical Manual of Mental Illnesses (DSM-5) Substance Abuse Disorder criteria, or presence of illicit substance abuse.
* They are currently undergoing another form of treatment other than supportive therapy (\>2 times per month).
* Any other condition/situation that the Investigator believes may interfere with participant safety, study conduct, or interpretation of study data.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Department of Defense / Congressionally Mandated Research Program (CDMRP)

UNKNOWN

Sponsor Role collaborator

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sarah Jackson

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sarah Jackson, MFT, PhD

Role: PRINCIPAL_INVESTIGATOR

The University of Texas Health Science Center, Houston

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Texas Health Science Center at Houston

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sarah Jackson, MFT, PhD

Role: CONTACT

(713) 486-2700

Ronald Acierno

Role: CONTACT

(713) 486-2863

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sarah Jackson, MFT, PhD i

Role: primary

713-486-2700

Ronald Acierno

Role: backup

(713) 486-2863

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSC-MS-24-0756

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.